The 24th International partnering conference BIO-Europe will be held on November 5th-7th, 2018 at the Bella Center in Copenhagen, Denmark. The event is expected to draw over 4,000 industry attendees for three days of high level networking, representing more than 2,000 companies from over 60 countries. BIO-Europe attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.
Our CEO Dirk Beher will take part to the panel discussion "The current climate of CNS R&D: Lessons learned and new research" on Monday, November 5th from 5:15 pm to 6:15 pm, at Bio-Europe (Room C2). The panel will cover the current climate of CNS R&D, specifically lessons learned from past failures and new research to advance the treatment of neurological disorders. CNS disorders are expected to make up 14.7 percent of the global disease burden by 2020, representing the largest burden of any disease group, according to the US National Institute of Mental Health. Despite decades of research and billions in investments, this sector has posed significant challenges and setbacks. However, ambitious novel research and new breakthroughs are changing the landscape. Experts in this field will highlight what is being done differently now and discuss the future of CNS in biopharma.